Medical Laboratory Bremen

What Medical Laboratory Bremen does

Medical Laboratory Bremen (MVZ Medizinisches Labor Bremen GmbH) is a German medical diagnostic laboratory founded in 1961, headquartered in Bremen, and operating as a wholly-owned subsidiary of Sonic Healthcare (ASX: SHL), the Australian multinational diagnostics group. The laboratory delivers a comprehensive diagnostic menu organized into eleven specialized departments — clinical chemistry, hematology, serology/immunology, molecular biology, microbiology, elemental analysis, therapeutic drug monitoring, toxicology, environmental toxicology, and hygiene — and fourteen clinical specializations spanning Alzheimer diagnostics, occupational medicine, endocrinology, coagulation, Lyme borreliosis, environmental medicine, and tick-borne diseases. Its proprietary Plasma-Protein-Dementia-Score (PPD-Score) is a CE-compliant combined biomarker panel for early-stage Alzheimer detection, and its Apolipoprotein E genotyping capability underpins both risk assessment and therapy eligibility testing for Eisai's Lecanemab (Leqembi).

The business generates revenue through four streams: statutory health insurance (GKV) billing via the Kassenärztliche Vereinigung Bremen (KVHB) on a quarterly cadence; private health insurance (PKV) billing under the GOÄ fee schedule; IGeL self-pay services for non-covered preventive and specialty tests; and a pharmaceutical-sponsored testing arrangement with Eisai for APO E4 genotyping. Go-to-market is primarily sales-led through referring physicians (Einsender), supplemented by a direct-to-consumer channel via "Mein Direktlabor" for individual health testing with physician consultation. Ordering and results delivery are handled through the star.net® Labor electronic platform (free, SSL-secured, automated updates) and the Pat-App for patients. The laboratory completed relocation to a new facility at Louis-Leitz-Straße 2 in the Oberneuland district in March 2026, with the official opening held in May 2026.

Name

Medical Laboratory Bremen

Legal name

MVZ Medizinisches Labor Bremen GmbH

Website

https://mlhb.de

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

101–250 employees

Short description

Medical Laboratory Bremen is a German medical diagnostic laboratory founded in 1961 and a subsidiary of Sonic Healthcare. It provides comprehensive clinical, molecular, toxicological, and environmental diagnostic testing to physicians and patients across the Bremen region.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

• Medical diagnostic services
• Clinical laboratory testing
• Molecular diagnostics
• Alzheimer biomarker testing
• Tick-borne disease diagnostics

Headquarters

HQ city

Bremen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Statutory Health Insurance (GKV): Laboratory diagnostic services billed to statutory health insurance funds through the Kassenärztliche Vereinigung Bremen (KVHB). Services covered under the quarterly billing system.
2. Private Health Insurance (PKV/GOÄ): Private medical services billed according to the German Scale of Fees for Physicians (GOÄ).
3. IGeL (Self-Pay Services): Individual health services paid directly by patients not covered by insurance, including preventive and specialized tests.
4. Pharmaceutical Partnership (Eisai): Free APO E4 genotyping offered to patients as part of Lecanemab therapy indication, funded through arrangement with Eisai pharmaceutical company.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Medical Laboratory Bremen provides comprehensive medical diagnostic testing services to physicians, hospitals, and patients across clinical chemistry, hematology, serology/immunology, molecular biology, microbiology, toxicology, and environmental toxicology. It offers specialized diagnostics in Alzheimer's disease (PPD-Score, APO E genotyping), tick-borne diseases (Lyme borreliosis, FSME), therapeutic drug monitoring, occupational medicine, and environmental toxicology, supported by the star.net® electronic ordering platform and the Mein Direktlabor direct-to-patient service.

Product overview

Medical Laboratory Bremen (Medizinisches Labor Bremen) operates as a comprehensive medical diagnostics laboratory offering a unified portfolio of laboratory testing services organized into specialized departments (Laborbereiche) and clinical specializations (Schwerpunkte). The core laboratory services span clinical chemistry, hematology, serology/immunology, molecular biology, microbiology, toxicology, and environmental toxicology. Key specialized offerings include Alzheimer's/dementia diagnostics (with CE-compliant blood biomarker testing and APO E genotyping), tick-borne disease testing, therapeutic drug monitoring, and occupational medicine services. The company provides patient-facing services through Mein Direktlabor (direct-to-consumer testing) and the Pat-App, while the star.net® Labor platform enables electronic laboratory communication for referring physicians. The laboratory is part of Sonic Healthcare network and is located in Bremen, Germany.

Differentiator

Problem solved

Functional benefit

Brands

• star.net Labor: Electronic laboratory communication platform for ordering tests and receiving results
• Mein Direktlabor

Products and services

• star.net® Labor Electronic laboratory communication platform enabling secure online test ordering, results viewing, and practice management integration for referring physicians and medical practices.
• Mein Direktlabor Direct-to-patient laboratory service offering individualized personal laboratory examinations with medical consultation by appointment, including IGeL self-pay options.
• Zeckenlabor (Tick Laboratory) Specialized laboratory diagnostic service for tick-borne diseases including Borreliosis (Lyme disease) and FSME (tick-borne encephalitis).
• Alzheimer-Demenz Diagnostik Comprehensive Alzheimer's and dementia diagnostic service including APO E genotyping, CE-compliant blood biomarker testing, and Plasma-Protein-Dementia-Score analysis for patients with MCI and early Alzheimer's disease.
• Pat-App Patient mobile application enabling access to laboratory services and test results for individual patients.
• e-Rechnung Electronic invoicing service for streamlined billing between laboratories and healthcare providers.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• EisaicoreStrategic or Co-development Partner · 1 September 2025Pharmaceutical partnership for APO E4 genotyping. Eisai provides funding to offer free genetic testing for patients being evaluated for Lecanemab (Leqembi) Alzheimer's therapy. Testing is required to determine eligibility due to safety concerns for homozygous APO E4 carriers.

Scale indicators3 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Synlab: Europe's largest medical diagnostics services provider, with broad routine and specialty lab offerings and extensive logistics. Overlaps directly with MLB on physician-channel diagnostics but operates at vastly greater scale across multiple countries.
• Medicover: European diagnostics and healthcare services provider operating clinical laboratories across multiple countries. Comparable lab diagnostics offering, physician-channel model, and overlapping specialty panels.
• Unilabs: European clinical diagnostics and laboratory services provider with comparable routine and specialty test menus and physician-referred GTM. Direct overlap on diagnostic testing services, broader geographic footprint.

Direct peers

• amedes Medizinische Dienstleistungen: Major German diagnostics group operating regional MVZ laboratories with similar physician-channel GTM and comparable specialty testing including endocrinology, genetics, and infectious disease. Direct overlap with MLB on esoteric and routine diagnostics in Germany.
• LADR Laborverbund Dr. Kramer & Kollegen: Federated network of regional German medical laboratories offering comparable routine and specialized diagnostic testing to physicians and hospitals. Closely comparable business model: physician-referred testing, similar specialty menu, German reimbursement exposure.
• Bioscientia (Sonic Healthcare Germany): Sister Sonic Healthcare subsidiary in Germany; comparable medical-diagnostics menu, physician-referred GTM, and shared corporate standards. Sister-company relationship and overlapping test portfolio make this a particularly close peer.
• Limbach Gruppe: German laboratory group with regional MVZ labs serving physicians and hospitals; comparable specialty diagnostics portfolio and German statutory/private reimbursement model.

Regional players

• MVZ Labor Volkmann Karlsruhe: Regional medical laboratory serving the Karlsruhe/Baden-Württemberg area with physician-referred diagnostics. Comparable regional German lab business model but non-overlapping geography.
• Labor Dr. Fenner und Kollegen: Northern German medical laboratory (Hamburg region) providing physician-referred clinical diagnostics. Similar business model and German statutory reimbursement exposure; geographic non-overlap but comparable Northern German regional lab profile.
• Labor Berlin: Hospital-affiliated medical laboratory serving Berlin and Brandenburg. Comparable medical-diagnostics service portfolio and German reimbursement model but different regional catchment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medizinisches-labor-bremen

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Laboratory Bremen